EX-99 2 tm2221739d1_ex99.htm EXHIBIT 99

Exhibit 99

 

 

Silicon Labs Grows Revenue 55% in Second Quarter 2022

 

IoT Leader Achieves Significant Revenue Growth in Industrial & Commercial and Home & Life Business Units

 

AUSTIN, Texas – July 27, 2022 – Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported robust financial results for the second quarter, which ended July 2, 2022. Revenue exceeded the top end of the guidance range at $263 million, up 13% sequentially and 55% year-on-year.

 

“We continue to gain momentum, building on strong design win performance, a growing opportunity funnel and market share expansion despite the challenging macro environment. We delivered record revenue in the quarter and operating results ahead of model, driving strong EPS growth," said Matt Johnson, President and Chief Executive Officer of Silicon Labs. “We just marked the one-year anniversary of becoming a pure-play IoT company, and we are more confident than ever in our ability to lead and scale in the large and growing IoT wireless market.”

 

Second Quarter Financial Highlights

 

Revenue increased to $263 million, up 13% sequentially and 55% year-on-year
Industrial & Commercial revenue for the quarter was $144 million, up 61% year-on-year
Home & Life revenue for the quarter was $119 million, up 49% year-on-year
Gross margin of 62% was slightly favorable due to product mix in the quarter

 

Results on a GAAP basis:

 

GAAP gross margin was 62%
GAAP R&D expenses were $84 million
GAAP SG&A expenses were $49 million
GAAP operating income as a percentage of revenue was 12%
GAAP diluted earnings per share were $0.60

 

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables were as follows:

 

Non-GAAP gross margin was 62%
Non-GAAP R&D expenses were $68 million
Non-GAAP SG&A expenses were $41 million
Non-GAAP operating income as a percentage of revenue was 21%
Non-GAAP diluted earnings per share were $1.17

 

 

 

 

Business Highlights

 

Announced a new Bluetooth Location Services solution using accurate, low-power Bluetooth devices to simplify Angle of Arrival (AoA) and Angle of Departure (AoD) location services. This new platform combines the industry-leading energy efficiency of Silicon Labs’ BG22 system-in-a package (SiP) modules and SoCs, which can operate for up to ten years on only a coin cell battery, with advanced software that can track assets, improve indoor navigation, and locate tags with sub-meter accuracy.

 

Completed the buyback of $350 million of the company's shares through the most recent open market repurchase program, resulting in the retirement of 2.5 million shares and bringing the year-to-date total for share repurchases to $600 million, retiring a total of 4.3 million shares. Additionally, the company’s board of directors has authorized a new $250 million open market repurchase program of the company’s common stock, through the end of 2023.

 

Announced the appointment of Robert (“Bob”) Conrad to the company's board of directors. Conrad brings nearly 40 years of experience in the semiconductor industry, most recently with NXP Semiconductors (NASDAQ: NXPI) as SVP of the Automotive Microcontrollers and Processors Business until his retirement in 2019. In addition, Bob brings significant experience driving strategic focus and successfully scaling businesses.

 

William (“Bill”) Wood announced he will not stand for reelection and will be retiring from the Silicon Labs board after 25 years of service. Bill joined the board of directors in 1997 and served as lead director from 2005-2021. His board tenure concludes at the 2023 annual meeting of stockholders.

 

“Bill Wood has been instrumental to Silicon Labs’ success since the very beginning of our journey,” said Johnson. “We’re grateful for his leadership throughout the years and wish him the very best.”

 

Business Outlook

 

The company expects third-quarter revenue to be in the range of $265 to $275 million. The company also estimates the following results:

 

On a GAAP basis:

 

GAAP gross margin of approximately 60%

GAAP operating expenses of approximately $137 million

GAAP effective tax rate of approximately 36%

GAAP diluted earnings per share between $0.49 to $0.59

 

On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:

 

Non-GAAP gross margin of approximately 60.5%

Non-GAAP operating expenses of approximately $113 million

 

 

 

 

Non-GAAP effective tax rate of approximately 26%

Non-GAAP diluted earnings per share between $1.08 to $1.18

 

Earnings Webcast and Conference Call

 

Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon 'Labs' website (www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at silabs.com/investors and make a replay available through August 3, 2022, online or by calling (877) 344-7529 (US) or (412) 317-0088 (international) and entering access code 2437694.

 

About Silicon Labs

 

Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions that transform industries, grow economies, and improve lives. silabs.com

 

Forward-Looking Statements

 

This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the timing and scope of share repurchases, and/or dividends; the impact of COVID-19 on the U.S. and global economy, including the restrictions on travel and transportation and other actions taken by governmental authorities and disruptions to the business of our customers or our global supply chain that have occurred or may occur in the future, the ongoing impact of COVID-19 on our employees and our ability to provide services to our customers and respond to their needs; risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest, including risks that demand and the supply chain may be adversely affected by military conflict (including between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. The level of share repurchases and/or dividends depends on market conditions and the level of other uses of cash. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

 

 

 

 

Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Thomas Haws, Investor Relations Manager, (512) 416-8500, investor.relations@silabs.com

 

 

 

 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

   Three Months Ended   Six Months Ended 
   July 2,
2022
   July 3,
2021
   July 2,
2022
   July 3,
2021
 
Revenues  $263,150   $169,492   $496,964   $327,349 
Cost of revenues   99,247    73,194    177,289    139,297 
Gross profit   163,903    96,298    319,675    188,052 
Operating expenses:                    
Research and development   83,511    64,832    161,053    128,847 
Selling, general and administrative   49,013    42,953    93,660    85,407 
Operating expenses   132,524    107,785    254,713    214,254 
Operating income (loss)   31,379    (11,487)   64,962    (26,202)
Other income (expense):                    
Interest income and other, net   3,445    475    4,944    1,624 
Interest expense   (1,667)   (6,486)   (3,347)   (17,810)
Income (loss) from continuing operations before income taxes   33,157    (17,498)   66,559    (42,388)
Provision for income taxes   10,994    1,165    22,683    3,157 
Equity-method earnings   (28)   172    1,166    1,898 
Income (loss) from continuing operations   22,135    (18,491)   45,042    (43,647)
Income from discontinued operations, net of income taxes   --    38,423    --    77,088 
                     
Net income  $22,135   $19,932   $45,042   $33,441 
                     
Basic earnings (loss) per share:                    
Continuing operations  $0.62   $(0.41)  $1.22   $(0.98)
Net income  $0.62   $0.44   $1.22   $0.75 
                     
Diluted earnings (loss) per share:                    
Continuing operations  $0.60   $(0.41)  $1.18   $(0.98)
Net income  $0.60   $0.44   $1.18   $0.73 
                     
Weighted-average common shares outstanding:                    
Basic   35,722    44,803    36,862    44,481 
Diluted   36,604    45,756    38,063    45,794 

 

 

 

 

Non-GAAP Financial Measurements

 

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

 

The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.

 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

  

Three Months Ended

July 2, 2022

 
Non-GAAP Income Statement Items 

GAAP

Measure

  

GAAP

Percent of
Revenue

   Stock
Compensation
Expense
   Intangible
Asset
Amortization
  

Non-
GAAP

Measure

  

Non-GAAP

Percent of
Revenue

 
Revenues  $263,150                          
                               
Gross profit   163,903    62.3%  $274   $--   $164,177    62.4%
                               
Research and development   83,511    31.7%   7,703    7,363    68,445    26.0%
                               
Selling, general and administrative   49,013    18.7%   6,412    1,479    41,122    15.6%
                               
Operating income   31,379    11.9%   14,389    8,842    54,610    20.8%
                               
  

Three Months Ended

July 2, 2022

 
Non-GAAP Earnings Per Share 

GAAP

Measure

  

Stock

Compensation
Expense*

   Intangible
Asset
Amortization*
  

Equity-Method

Investment
Adjustments*

  

Income

Tax

Adjustments

  

Non-

GAAP

Measure

 
Net income  $22,135   $14,389   $8,842   $28   $(2,631)  $42,763 
                               
Diluted shares outstanding   36,604                        36,604 
                               
Diluted earnings per share  $0.60                       $1.17 

 

* Represents pre-tax amounts

 

 

 

 

Unaudited Forward-Looking Statements Regarding Business Outlook

(In millions, except per share data)

 

 

Three Months Ending

October 1, 2022

 
Business Outlook   

GAAP

Measure

    

Non-GAAP

Adjustments*

    

Non-GAAP

Measure

 
Gross margin   60%   0.5%   60.5%
                
Operating expenses  $137   $(24)  $113 
                
Effective tax rate   36%   (10)%   26%
                
Diluted earnings per share - low  $0.49   $0.59   $1.08 
                
Diluted earnings per share - high  $0.59   $0.59   $1.18 

 

* Non-GAAP adjustments include the following estimates: stock compensation expense of $16.3 million, intangible asset amortization of $8.1 million and the associated tax impact from the aforementioned items.

 

 

 

 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

  

July 2,

2022

   January 1,
2022
 
Assets          
Current assets:          
Cash and cash equivalents  $504,850   $1,074,623 
Short-term investments   972,845    964,582 
Accounts receivable, net   72,106    98,313 
Inventories   74,026    49,307 
Prepaid expenses and other current assets   86,138    51,748 
Total current assets   1,709,965    2,238,573 
Property and equipment, net   149,447    146,516 
Goodwill   376,389    376,389 
Other intangible assets, net   99,784    118,978 
Other assets, net   83,813    77,839 
Total assets  $2,419,398   $2,958,295 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable  $95,365   $47,327 
Current portion of convertible debt, net   --    450,599 
Deferred revenue and returns liability   10,696    13,849 
Other current liabilities   126,058    157,052 
Total current liabilities   232,119    668,827 
Convertible debt, net   528,564    -- 
Other non-current liabilities   53,371    77,044 
Total liabilities   814,054    745,871 
Commitments and contingencies          
Stockholders’ equity:          
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued   --    -- 
Common stock – $0.0001 par value; 250,000 shares authorized;
34,223 and 38,481 shares issued and outstanding at
July 2, 2022 and January 1, 2022, respectively
   3    4 
Retained earnings   1,619,396    2,214,839 
Accumulated other comprehensive loss   (14,055)   (2,419)
Total stockholders’ equity   1,605,344    2,212,424 
Total liabilities and stockholders’ equity  $2,419,398   $2,958,295 

 

 

 

 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

   Six Months Ended 
  

July 2,
2022

   July 3,
2021
 
Operating Activities          
Net income  $45,042   $33,441 
Adjustments to reconcile net income to cash provided by operating activities
of continuing operations:
          
Income from discontinued operations, net of income taxes   --    (77,088)
Depreciation of property and equipment   10,561    8,184 
Amortization of other intangible assets   19,194    22,902 
Amortization of debt discount and debt issuance costs   994    11,822 
Loss on extinguishment of convertible debt   3    3,370 
Stock-based compensation expense   27,264    22,620 
Equity-method earnings   (1,166)   (1,898)
Deferred income taxes   (9,344)   (5,644)
Changes in operating assets and liabilities:          
Accounts receivable   26,207    (4,377)
Inventories   (24,714)   (4,447)
Prepaid expenses and other assets   (25,286)   (3,591)
Accounts payable   25,606    14,711 
Other current liabilities and income taxes   (3,418)   (10,626)
Deferred revenue and returns liability   (3,153)   (175)
Other non-current liabilities   (4,416)   (3,464)
Net cash provided by operating activities of continuing operations   83,374    5,740 
           
Investing Activities          
Purchases of marketable securities   (554,267)   (80,426)
Sales of marketable securities   27,404    186,626 
Maturities of marketable securities   511,296    100,023 
Purchases of property and equipment   (12,322)   (10,779)
Purchases of other assets   --    (578)
Net cash provided by (used in) investing activities of continuing operations   (27,889)   194,866 
           
Financing Activities          
Payments on debt   (21)   (140,572)
Repurchases of common stock   (579,040)   (18,982)
Payment of taxes withheld for vested stock awards   (13,958)   (19,732)
Proceeds from the issuance of common stock   6,365    8,388 
Net cash used in financing activities of continuing operations   (586,654)   (170,898)
           
Discontinued Operations          
Operating activities   (38,604)   72,674 
Investing activities   --    (2,018)
Net cash provided by (used in) discontinued operations   (38,604)   70,656 
           
Increase (decrease) in cash and cash equivalents   (569,773)   100,364 
Cash and cash equivalents at beginning of period   1,074,623    202,720 
Cash and cash equivalents at end of period  $504,850   $303,084